Walleye Capital’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,130
| Closed | -$568K | – | 1967 |
|
|
2025
Q1 | $568K | Buy |
+14,130
| New | +$568K | ﹤0.01% | 1032 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2561 |
|
|
2024
Q2 | – | Sell |
-105,662
| Closed | -$7.41M | – | 2712 |
|
|
2024
Q1 | $7.41M | Buy |
105,662
+67,999
| +181% | +$4.77M | 0.01% | 337 |
|
|
2023
Q4 | $3.14M | Buy |
+37,663
| New | +$3.14M | 0.01% | 497 |
|
|
2023
Q3 | – | Sell |
-25,323
| Closed | -$826K | – | 2426 |
|
|
2023
Q2 | $826K | Buy |
+25,323
| New | +$826K | ﹤0.01% | 809 |
|
|
2023
Q1 | – | Sell |
-214,204
| Closed | -$9.81M | – | 2260 |
|
|
2022
Q4 | $9.81M | Buy |
214,204
+99,560
| +87% | +$4.56M | 0.18% | 121 |
|
|
2022
Q3 | $5.56M | Buy |
114,644
+29,784
| +35% | +$1.44M | 0.11% | 198 |
|
|
2022
Q2 | $3.33M | Buy |
84,860
+6,580
| +8% | +$259K | 0.09% | 239 |
|
|
2022
Q1 | $2.88M | Buy |
+78,280
| New | +$2.88M | 0.08% | 254 |
|
|
2020
Q2 | – | Sell |
-31,515
| Closed | -$372K | – | 632 |
|
|
2020
Q1 | $372K | Buy |
31,515
+65
| +0.2% | +$767 | 0.08% | 202 |
|
|
2019
Q4 | $333K | Buy |
+31,450
| New | +$333K | 0.02% | 268 |
|
|
2019
Q3 | – | Sell |
-9,600
| Closed | -$108K | – | 607 |
|
|
2019
Q2 | $108K | Buy |
+9,600
| New | +$108K | 0.01% | 244 |
|